Financials

Chemed Corp financials

CHE Health Care Providers and Services

Chemed Corp, founded in 1968 and headquartered in Cincinnati, Ohio, United States, operates through its two primary segments: VITAS Healthcare, which provides hospice and palliative care services, and Roto-Rooter, known for emergency plumbing services. Led by CEO John Z. Block since 2015, the company has achieved notable market positions with approximately 20% of the U.S. hospice care market and an estimated 40% share in plumbing repairs nationally. It generates revenue from a diversified customer base through efficient, scale-driven operations. Future investments in technology and network expansion are set to drive its continued growth.

Snapshot

Chemed Corp reported $2.53B in revenue in fiscal 2025, up 4.1% year over year, with an operating margin of 13.4%.

Revenue (FY2025): $2.53B
YoY growth: +4.1%
Operating margin: 13.4%
Direction: Expanding

Financial statements

In thousands, USD · annual

In thousands, USD
	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenues	2,529,980	2,431,290	2,264,420	2,134,960
Cost of Sales	1,706,790	1,576,940	1,465,600	1,369,880
Gross Profit	823,184	854,348	798,815	765,086
Selling, General & Administrative Expenses	417,188	424,360	395,120	358,727
Depreciation & Amortization Expenses	64,841	63,049	60,865	59,172
Other Operating Expenses	2,909	446	2,261	3,691
Operating Profit	338,246	366,493	340,569	343,496
Interest Expense	(1,750)	(1,780)	(3,108)	(4,584)
Non-Operating Income	19,282	34,752	12,906	(9,233)
Total Non-Operating Income	17,532	32,972	9,798	(13,817)
Income Before Provision for Income Taxes	355,778	399,465	350,367	329,679
Provision for Income Taxes	90,540	97,466	77,858	80,055
Consolidated Net Income	265,238	301,999	272,509	249,624
Net Income Attributable to Common Shareholders	265,238	301,999	272,509	249,624
Basic EPS	18.42	20.10	18.11	16.72
Diluted EPS	18.34	19.89	17.93	16.53
Basic Weighted Average Shares Outstanding	14,398	15,024	15,050	14,929
Diluted Weighted Average Shares Outstanding	14,460	15,186	15,200	15,099
Shares Outstanding	13,710	14,556	15,035	14,875

In thousands, USD
	FY 2025	FY 2024	FY 2023	FY 2022
Cash and Cash Equivalents	74,515	178,350	263,958	74,126
Total Cash and Cash Equivalents	74,515	178,350	263,958	74,126
Accounts Receivable	182,575	171,163	181,511	139,408
Total Trade Receivables	182,575	171,163	181,511	139,408
Inventories	7,543	8,193	12,004	10,272
Other Current Assets	37,983	37,042	43,370	48,806
Total Current Assets	302,616	394,748	500,843	272,612
Net Property, Plant & Equipment	336,813	328,160	330,227	335,376
Net Intangible Assets	82,764	92,206	90,264	99,726
Goodwill	666,999	666,744	585,017	581,295
Long-Term Investments	140,347	130,960	106,126	93,196
Other Long-Term Assets	8,650	55,757	55,618	59,807
Total Assets	1,538,190	1,668,580	1,668,100	1,442,010
Accounts Payable	64,459	44,146	64,034	41,884
Accrued Expenses	122,887	156,369	153,807	150,321
Current Portion of Long-Term Debt	—	—	—	5,000
Current Portion of Leases	40,892	42,306	38,635	38,996
Other Current Liabilities	58,892	42,874	55,574	61,004
Total Current Liabilities	287,130	285,695	312,050	297,205
Long-Term Debt	—	—	—	92,500
Leases	102,867	98,538	100,776	110,513
Other Long-Term Liabilities	168,787	165,349	147,393	143,079
Total Long-Term Liabilities	271,654	263,887	248,169	346,092
Total Liabilities	558,784	549,582	560,219	643,297
Common Stock	37,595	37,422	37,184	36,796
Treasury Stock	(3,608,120)	(3,126,660)	(2,719,590)	(2,588,150)
Additional Paid-in Capital	1,592,200	1,484,180	1,341,270	1,149,900
Accumulated Other Comprehensive Income	2,355	2,223	2,082	2,247
Retained Earnings	2,955,380	2,721,830	2,446,930	2,197,920
Total Common Shareholders' Equity	979,405	1,118,990	1,107,880	798,715
Total Shareholders' Equity	979,405	1,118,990	1,107,880	798,715
Total Liabilities and Shareholders' Equity	1,538,190	1,668,580	1,668,100	1,442,010

In thousands, USD
	FY 2025	FY 2024	FY 2023	FY 2022
Net Income	265,238	301,999	272,509	249,624
Depreciation & Amortization	64,841	63,049	60,865	59,172
Share-Based Compensation Expense	38,680	52,109	40,793	33,612
Other Adjustments	(4,198)	(9,567)	(5,397)	994
Changes in Trade Receivables	(11,596)	10,678	(41,488)	(2,414)
Changes in Inventories	650	3,831	(1,732)	(162)
Changes in Accounts Payable	(5,194)	(9,279)	(9,348)	15,343
Changes in Income Taxes Payable	(6,217)	2,182	11,748	(996)
Changes in Other Operating Activities	46,068	2,495	2,349	(45,287)
Cash from Operating Activities	388,272	417,497	330,299	309,886
Capital Expenditure	(62,795)	(49,531)	(56,854)	(57,325)
Proceeds from Sale of Property, Plant & Equipment	4,568	3,315	640	2,330
Payments for Business Acquisitions	(225)	(97,400)	(3,994)	(3,529)
Other Investing Activities	(888)	(295)	(434)	(878)
Cash from Investing Activities	(59,340)	(143,911)	(60,642)	(59,402)
Issuance of Short-Term Debt	—	—	—	121,800
Repayments of Short-Term Debt	—	—	—	(306,800)
Net Issuance / (Repayments) of Short-Term Debt	—	—	—	(185,000)
Issuance of Long-Term Debt	—	—	—	100,000
Repayments of Long-Term Debt	—	—	(97,500)	(2,500)
Net Issuance / (Repayments) of Long-Term Debt	—	—	(97,500)	97,500
Issuance of Common Shares	27,152	56,517	102,192	44,968
Repurchases of Common Shares	(440,319)	(370,846)	(77,254)	(130,126)
Net Issuance / (Repurchases) of Common Shares	(413,167)	(314,329)	24,938	(85,158)
Common Share Dividends Paid	(31,695)	(27,092)	(23,502)	(22,017)
Other Financing Activities	12,095	(17,773)	16,239	(14,578)
Cash from Financing Activities	(432,767)	(359,194)	(79,825)	(209,253)
Increase / (Decrease) in Cash, Cash Equivalents and Restricted Cash	(103,835)	(85,608)	189,832	41,231

Key metrics

latest fiscal year

$5.87B

Market Cap

23.33x

P/E

2.32x

P/S

14.72x

EV/EBITDA

25.3%

Return on Equity

18.7%

Return on Invested Capital

1.05x

Current Ratio

0.5%

Dividend Yield

12.9%

Free Cash Flow Margin

Quarterly trend

last 8 quarters

Quarter	Revenue	YoY growth	Operating margin	Operating income
Q1 2026	$658M	+1.6%	12.9%	$85M
Q4 2025	$639M	+-0.1%	15.7%	$101M
Q3 2025	$625M	+3.1%	12.0%	$75M
Q2 2025	$619M	+3.8%	11.0%	$68M
Q1 2025	$647M	—	14.6%	$95M
Q4 2024	$640M	—	17.8%	$114M
Q3 2024	$606M	—	15.2%	$92M
Q2 2024	$596M	—	14.8%	$88M

Revenue by quarter$M

$596M

Q2 '24

$606M

Q3 '24

$640M

Q4 '24

$647M

Q1 '25

$619M

Q2 '25

$625M

Q3 '25

$639M

Q4 '25

$658M

Q1 '26

Margins

latest fiscal year

32.5%

Gross margin

13.4%

Operating margin

10.5%

Net margin

SourceCompany financial filings (income statement, balance sheet, cash flow) Last updated2026-06-16

Snapshot

Financial statements

Key metrics

Quarterly trend

Margins

More on Chemed Corp

See how VectorShift works for your firm